Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: The NICOLE study

Heart

Volumn 89, Issue 8, 2003, Pages 887-892

  Dens, Joseph A ^a   Desmet, W J ^a   Coussement, P ^a   De Scheerder, I K ^a   Kostopoulos, K ^a   Kerdsinchai, P ^a   Supanantaroek, C ^a   Piessens, J H ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

NISOLDIPINE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ANKLE EDEMA; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME;

EID: 0042167444     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.8.887     Document Type: Article

References (14)

1. Lüscher T, Wenzel R, Moreau P, et al. Vascular protective effects of ACE inhibitors and calcium antagonists: theoretical basis for a combination therapy in hypertension and other cardiovascular diseases. Cardiovasc Drugs Ther 1995;9:509-23.
2. Henry PD, Bentley KI. Suppression of atherogenesis in cholesterol-fed rabbits treated with nifedipine. J Clin Invest 1981;68:1366-9.
3. Willis AL, Nagel B, Churchill V, et al. Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits. Atherosclerosis 1985;5:250-5.
4. Lichtlen P, Hugenholtz P, Rafflenbeul W, et al, on behalf of the INTACT Group Investigators. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the international nifedipine trial on antiatherosclerotic therapy (INTACT). Lancet 1990;335:109-13.
5. Waters D, Lespérance J, Francetich M, et al. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary arteriosclerosis. Circulation 1990;82:940-53.
6. Furberg C, Psaty B, Meyer J. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:326-31.
7. Dens JA, Desmet WJ, Coussement P, et al. Usefulness of nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). Am J Cardiol 2001;87:28-33.
8. Desmet W, Willems JL, Vrolix M, et al. Intra- and interobserver variability of a fast on-line quantitative coronary angiographic system. Int J Card Imaging 1993;9:249-56.
9. Desmet W, De Scheerder I, Beatt K, et al. In vivo comparison of different quantitative edge detection systems used for measuring coronary arterial diameters. Cathet Cardiovasc Diagn 1995;34:72-80.
10. Pitt B, Byington R, Furberg C, et al, for the Prevent investigators. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000;102:1503-10.
11. Expert Panel. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-97.
12. Langtry H, Spencer C. Nisoldipine coat core; a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischemic heart disease. Drugs 1997;53:867-84.
13. Pahor M, Guralnik JM, Corti MC, et al. Long-term survival and use of antihypertensive medication in older persons. J Am Geriatr Soc 1995;43:1191-7.
14. Pahor M, Guralnik J. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996;347:1061-5.